These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 19403853

  • 1. The effects of repeated opioid administration on locomotor activity: I. Opposing actions of mu and kappa receptors.
    Smith MA, Greene-Naples JL, Lyle MA, Iordanou JC, Felder JN.
    J Pharmacol Exp Ther; 2009 Aug; 330(2):468-75. PubMed ID: 19403853
    [Abstract] [Full Text] [Related]

  • 2. The effects of repeated opioid administration on locomotor activity: II. Unidirectional cross-sensitization to cocaine.
    Smith MA, Greene-Naples JL, Felder JN, Iordanou JC, Lyle MA, Walker KL.
    J Pharmacol Exp Ther; 2009 Aug; 330(2):476-86. PubMed ID: 19403852
    [Abstract] [Full Text] [Related]

  • 3. Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.
    Smith MA, Gordon KA, Craig CK, Bryant PA, Ferguson ME, French AM, Gray JD, McClean JM, Tetirick JC.
    Psychopharmacology (Berl); 2003 May; 167(3):265-73. PubMed ID: 12669175
    [Abstract] [Full Text] [Related]

  • 4. The mu/kappa agonist nalbuphine attenuates sensitization to the behavioral effects of cocaine.
    Smith MA, Cole KT, Iordanou JC, Kerns DC, Newsom PC, Peitz GW, Schmidt KT.
    Pharmacol Biochem Behav; 2013 Mar; 104():40-6. PubMed ID: 23305678
    [Abstract] [Full Text] [Related]

  • 5. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J, Kendig JJ.
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [Abstract] [Full Text] [Related]

  • 6. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
    Craft RM, McNiel DM.
    Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
    [Abstract] [Full Text] [Related]

  • 7. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK, Meert TF.
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [Abstract] [Full Text] [Related]

  • 8. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
    Zhang L, Walker EA, Sutherland J, Young AM.
    Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
    [Abstract] [Full Text] [Related]

  • 9. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists.
    Carey GJ, Bergman J.
    J Pharmacol Exp Ther; 2001 Apr; 297(1):215-23. PubMed ID: 11259547
    [Abstract] [Full Text] [Related]

  • 10. Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption.
    White DA, Ballard ME, Harmon AC, Holtzman SG.
    Brain Res Bull; 2008 Aug 15; 76(6):597-604. PubMed ID: 18598850
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
    Mellon RD, Bayer BM.
    Brain Res; 1998 Apr 06; 789(1):56-67. PubMed ID: 9602057
    [Abstract] [Full Text] [Related]

  • 13. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice.
    Narita M, Takahashi Y, Takamori K, Funada M, Suzuki T, Misawa M, Nagase H.
    Jpn J Pharmacol; 1993 May 06; 62(1):15-24. PubMed ID: 8393497
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
    Morgan D, Picker MJ.
    Psychopharmacology (Berl); 1998 Nov 06; 140(1):20-8. PubMed ID: 9862398
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.
    Walsh SL, Chausmer AE, Strain EC, Bigelow GE.
    Psychopharmacology (Berl); 2008 Jan 06; 196(1):143-55. PubMed ID: 17909753
    [Abstract] [Full Text] [Related]

  • 19. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M.
    Brain Res; 2006 Apr 14; 1083(1):61-9. PubMed ID: 16530171
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.